DIRS.INFO The most relevant business & tech news

☆ Bayer investor calls for swift replacement of CEO -newspaper
▼ + stars: | 2023-01-28 | by ( ) www.reuters.com time to read: +2 min

FRANKFURT, Jan 28 (Reuters) - Bayer (BAYGn.DE) investor Deka has called for CEO Werner Baumann to be replaced ahead of his scheduled departure, adding to mounting pressure on the German drugmaker. "There is a window of opportunity for Chairman Norbert Winkeljohann to act before the annual general meeting at the end of April. He has to seize that opportunity, otherwise the pressure on him will increase as well," Speich added. "Generally speaking we are always open to a constructive dialogue with our stakeholders," a Bayer spokesperson said, declining to comment specifically on the interview. Another activist investment fund, hedge fund veteran Jeffrey Ubben's Inclusive Capital Partners, said this month it had also acquired a stake in Bayer.

WASHINGTON, Jan 23 (Reuters) - U.S. farm and trade officials raised "grave concerns" over Mexico's agricultural biotechnology policies in meetings with their Mexican counterparts on Monday, as lingering disagreements threaten decades of booming corn trade between the neighbors. The United States accounts for most of Mexican corn imports. U.S. officials traveled to Mexico to discuss Mexico's approach to agricultural biotech products. Mexico's agriculture ministry declined to comment, while the country's economy ministry, which handles trade, did not immediately provide comment. Mexican officials have said they will keep importing GM corn for animal feed.

☆ GSK, Sanofi shares brighten as thousands of Zantac lawsuits are dismissed
▼ + stars: | 2022-12-07 | by ( Reuters Staff | ) www.reuters.com time to read: +2 min

LONDON/PARIS (Reuters) - Shares of GSK and Sanofi surged in early trading on Wednesday, following the dismissal of thousands of U.S. lawsuits claiming that the heartburn drug Zantac caused cancer. Zantac, first approved in 1983, became the world’s best selling medicine in 1988 and one of the first-ever drugs to top $1 billion in annual sales. The decision bodes well for state cases too, they wrote in a note. Shares of Haleon, which comprises consumer health assets once owned by GSK and Pfizer and spun out as an independent company in July, also rose 5%. Barclays analysts said they viewed Zantac as substantially derisked, “leaving Haleon investible again for those without the appetite for pharma litigation risk.”

☆ Mexico not buying U.S. yellow corn as GM ban looms, Lopez Obrador says
▼ + stars: | 2022-11-09 | by ( Marianna Parraga | ) www.reuters.com time to read: +3 min

The United States wanted to sell Mexico more yellow corn and Mexico declined, Lopez Obrador said in a regular news conference. "There is a market for it, but the government cannot make a purchase because we do not want GM," Lopez Obrador said, citing a lack of scientific investigation into its effects. Lopez Obrador did not specify who made the request to sell more corn, the amount of the requested sale or the time frame. Mexico is ready to halve its U.S. imports of yellow corn when the decree goes into effect and is considering direct agreements with farmers to secure non-GM yellow corn imports, the country's deputy agriculture minister said in October. Chicago Board of Trade corn futures fell on Wednesday after the news, with the benchmark December contract down 6 cents a bushel at a two-month low of $6.61-1/2 a bushel.

☆ GSK lifts earnings view again after forecast-beating quarter
▼ + stars: | 2022-11-02 | by ( Natalie Grover | ) www.reuters.com time to read: +2 min

[1/2] GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. Shingrix generated sales of 760 million pounds ($873 million) compared with the GSK-compiled analyst consensus forecast for 685 million pounds. In July, GSK had predicted 2022 sales growth of 6% to 8% and adjusted operating profit to climb by 13% to 15%, both increases on forecasts issued in February. GSK said it had incurred a charge of 45 million pounds in the third quarter, primarily reflecting provisions for increased legal fees related to heartburn drug Zantac. Originally marketed by a forerunner of GSK, Zantac has been sold by several companies at different times, including Pfizer (PFE.N), Boehringer Ingelheim and Sanofi (SASY.PA) as well as a plethora of generic drugmakers.

☆ New GSK shines brighter with another forecast upgrade
▼ + stars: | 2022-11-02 | by ( Natalie Grover | ) www.reuters.com time to read: +3 min

Shingrix generated quarterly sales of 760 million pounds ($873 million), compared with the GSK-compiled analyst consensus forecast for 685 million pounds. GSK shares hit a 2-1/2 month high of 1,470.2 pence in early trade and were last up 1% at 1,461.3 pence. GSK said it had incurred a charge of 45 million pounds in the third quarter, primarily reflecting provisions for increased legal fees related Zantac. Originally marketed by a forerunner of GSK, Zantac has been sold by companies including Pfizer (PFE.N), Boehringer Ingelheim and Sanofi (SASY.PA), as well as many generic drugmakers. GSK reported a third-quarter adjusted profit of 46.9 pence per share on sales of about 7.83 billion pounds, topping analysts' forecasts for 40.1 pence and 7.32 billion pounds.

☆ A potentially cancer-causing chemical is sprayed on much of America’s farmland. Here is where it is used the most.
▼ + stars: | 2022-10-28 | by ( Danica Jefferies | Danica Jefferies Is An Intern With The Data Graphics Team For Nbc News Digital. | ) www.nbcnews.com time to read: +9 min

For those only exposed through food, the EPA says that glyphosate residues on food are safe up to certain thresholds. The chemical giant Monsanto introduced glyphosate in its product Roundup in 1974. “Glyphosate is the most widely used chemical weedkiller in human history because of genetic engineering,” said Dave Murphy, the founder of Food Democracy Now, an advocacy group that tests glyphosate in food. “It’s sprayed ubiquitously and Monsanto has, for decades, just maintained that it’s the safest agricultural chemical ever made.”The EPA’s safety limits for glyphosate exposure from food are twice the levels allowed in the European Union. The company pointed NBC News to other studies — including some that it has sponsored — that either refuted a link to cancer or challenged the relationship between acres sprayed and exposure levels.

"There are many alternatives to importing non-GMO yellow corn from the United States," Suarez said in an interview on Wednesday. It was the strongest indication yet from Mexico's Agriculture Ministry that the ban will hit yellow corn destined for livestock feed. The 2020 decree by Mexico President Andres Manuel Lopez Obrador aims to phase out GM corn and the herbicide glyphosate by 2024. Yellow corn imports had become more expensive than domestic production, another incentive for farmers to make the switch, Suarez said. The government was working to make agreements with local corn growers to specifically increase yellow corn production to 6 million tonnes, he added.

☆ A potentially cancer-causing chemical is sprayed on much of America’s produce. How high is exposure near you?
▼ + stars: | 2022-10-10 | by ( Danica Jefferies | Danica Jefferies Is An Intern With The Data Graphics Team For Nbc News Digital. | ) www.nbcnews.com time to read: +6 min

The chemical giant Monsanto introduced glyphosate in its product Roundup in 1974. “It’s sprayed ubiquitously and Monsanto has, for decades, just maintained that it’s the safest agricultural chemical ever made.”The EPA’s safety limits for glyphosate exposure from food are twice the levels allowed in the European Union. Additionally, two reports by organic advocacy groups found glyphosate in food products including cereals, cookies, crackers and sandwich bread. The EPA concluded in 2020 that glyphosate posed “no risks to human health” and was not likely to cause cancer. But a federal appeals court rejected that determination in June, stating that the EPA did not adequately assess the risks to endangered species and human health.

☆ Haleon rejects Zantac indemnification requests from GSK, Pfizer
▼ + stars: | 2022-09-20 | by ( ) www.reuters.com time to read: +2 min

REUTERS/Brendan McDermidLONDON, Sept 20 (Reuters) - Haleon (HLN.L) on Tuesday said it had notified GSK (GSK.L) and Pfizer (PFE.N) that it had rejected their requests for indemnification in relation to U.S.-based litigation over the heartburn drug, Zantac. More than 2,000 legal cases related to Zantac have been filed in the United States over allegations that the compound contains a probable carcinogen. Zantac, originally marketed by a forerunner of GSK, has been sold by several companies at different times, including Pfizer, Boehringer Ingelheim and Sanofi (SASY.PA) as well as a plethora of generic drugmakers. Haleon - alongside GSK, Sanofi and Pfizer - saw billions wiped off their market value last month as uncertainty around the outcome of the impending litigation triggered investor concern, although some of those losses have been since pared back. However, in August, Haleon clarified that it never marketed Zantac in any form in the U.S., either as Haleon or as GSK consumer healthcare.

☆ As war, drought hit global crops, Argentina gambles on GM wheat
▼ + stars: | 2022-09-20 | by ( Maximilian Heath | ) www.reuters.com time to read: +9 min

It was the first GM wheat strain in the world to receive such approval. No other global seed company has publicly endeavored to develop GM wheat since 2004, when giant seed maker Monsanto, now owned by Bayer AG, dropped plans to develop GM wheat that could withstand its weed killer Roundup. In 2020 he had threatened to halt wheat imports from Argentina after its government approved Bioceres' GM wheat. A new landmark is the recent approval in Nigeria, the only country to fully approve imports of HB4 wheat grains. Trucco said Russia's invasion of Ukraine and severe droughts in Europe and China had shifted the needle on drought-tolerant GM wheat.

Search resuls for: "Glyphosate"

11 mentions found